1. Home
  2. VLYPO vs BRTX Comparison

VLYPO vs BRTX Comparison

Compare VLYPO & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valley National Bancorp 5.50% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series B

VLYPO

Valley National Bancorp 5.50% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series B

N/A

Current Price

$25.08

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$1.21

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VLYPO
BRTX
Founded
N/A
1997
Country
United States
United States
Employees
3732
N/A
Industry
Major Banks
Managed Health Care
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
9.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VLYPO
BRTX
Price
$25.08
$1.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
64.8K
Earning Date
N/A
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$383,400.00
Revenue This Year
N/A
$112.14
Revenue Next Year
N/A
$139.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.70
52 Week Low
N/A
$0.98
52 Week High
N/A
$2.55

Technical Indicators

Market Signals
Indicator
VLYPO
BRTX
Relative Strength Index (RSI) 45.43 52.59
Support Level $24.96 $1.04
Resistance Level $25.59 $1.16
Average True Range (ATR) 0.18 0.09
MACD -0.04 0.02
Stochastic Oscillator 26.43 88.16

Price Performance

Historical Comparison
VLYPO
BRTX

About VLYPO Valley National Bancorp 5.50% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series B

Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: